A carregar...
MON-LB054 Activity of Prolactin Receptor Antagonist-Rapamycin Conjugate in Glioblastoma Multiform
Background: Glioblastoma multiform (GBM) is the most common and aggressive primary brain tumor in humans, accounting for approximately 12-15% of all intracranial tumors, with a median survival of 15 months. Although GBM is not considered a hormone sensitive cancer but recent studies showed significa...
Na minha lista:
| Publicado no: | J Endocr Soc |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Endocrine Society
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6551127/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-MON-LB054 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|